Clinical Features and Outcomes of Pediatric MYH7-Related Dilated Cardiomyopathy

Fernando de Frutos1,2,3,4, Juan Pablo Ochoa1,2,3,4, Gregory Webster5

  • 1Heart Failure and Inherited Cardiac Diseases Unit, Department of Cardiology, Hospital Universitario Puerta de Hierro IDIPHISA Madrid Spain.

Insights

Pediatric dilated cardiomyopathy (DCM) caused by MYH7 gene variants often begins early in life and has a poor prognosis. Advanced New York Heart Association class and low left ventricular ejection fraction predict heart failure events.

Area of Science:

  • Cardiology
  • Genetics
  • Pediatrics

Background:

  • Genetic variants in the MYH7 gene are the most common cause of pediatric genetic dilated cardiomyopathy (DCM).
  • Limited studies have described the clinical features and prognosis of pediatric MYH7-related DCM.
  • This study aims to characterize clinical presentations, analyze variant locations, and identify prognostic factors in this patient population.

Purpose of the Study:

  • To describe the clinical features of pediatric patients with MYH7-related DCM.
  • To analyze the location of MYH7 variants.
  • To identify predictors of poor prognosis in pediatric MYH7-related DCM.

Main Methods:

  • Retrospective analysis of clinical records from 44 pediatric patients (<18 years) with pathogenic/likely pathogenic MYH7 variants diagnosed with DCM.
  • Data collected from 13 international centers.
  • Risk factors for end-stage heart failure (heart transplantation or heart failure-related death) were explored.

Main Results:

  • Fifty percent of patients were diagnosed before 6 months of age, with 16% diagnosed at birth.
  • Left ventricular (LV) hypertrabeculation was present in 38% of patients, particularly those with variants in the MYH7 head domain.
  • At a median follow-up of 6.1 years, 36% of patients required heart transplantation or died from heart failure. Advanced New York Heart Association class (HR, 7.67) and LV ejection fraction ≤35% (HR, 4.00) were significant predictors of adverse outcomes.

Conclusions:

  • Pediatric MYH7-related DCM is characterized by early onset, frequent LV hypertrabeculation, and a generally poor prognosis.
  • Advanced New York Heart Association class and low LV ejection fraction are key predictors of end-stage heart failure.
  • These findings highlight the need for early diagnosis and intensive management strategies for affected children.
Abstract

Related Concept Videos

Myocarditis II: Clinical features and Diagnostic Tests01:27

Myocarditis II: Clinical features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
2
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
4
Mitral Regurgitation II: Clinical features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
5
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
3
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
2